Related Experiment Video
Updated: Aug 15, 2026

Assessing the Secretory Capacity of Pancreatic Acinar Cells
Published on: August 28, 2014
Serum amylase and lipase alone are not cost-effective screening methods for pediatric pancreatic trauma
William T Adamson1, Andre Hebra, Patrick B Thomas
1Department of Surgery, Division of Pediatric Surgery, Medical University of South Carolina, Charleston, South Carolina 29425, USA.
Insights
Serum amylase and lipase tests are not reliable or cost-effective for screening pediatric pancreatic trauma. Elevated levels often lead to unnecessary imaging, increasing healthcare costs without confirming injury.
Area of Science:
- Pediatric Trauma Surgery
- Gastrointestinal Radiology
- Biochemical Diagnostics
Background:
- Pancreatic injury is uncommon in pediatric trauma cases.
- Diagnosis relies on clinical signs, imaging, and labs, but serum markers lack strong correlation.
- This study evaluates the utility and cost-effectiveness of serum amylase and lipase in pediatric pancreatic injury.
Purpose of the Study:
- To assess the diagnostic value of serum amylase and lipase levels in pediatric trauma patients.
- To determine the cost-effectiveness of using these serum markers for screening pancreatic injuries.
- To analyze the impact of elevated serum amylase/lipase on subsequent diagnostic imaging.
Main Methods:
- Retrospective analysis of 1,821 pediatric trauma patients over 64 months.
- Identified 8 cases of pancreatic injury among 195 patients with intra-abdominal trauma.
- Correlated serum amylase/lipase (AMY/LIP) levels with confirmed pancreatic injuries and diagnostic imaging findings.
Main Results:
- Serum AMY/LIP measured in 507 patients; 116 (23%) had elevated levels.
- Five of eight patients with pancreatic injury had elevated AMY/LIP.
- Elevated AMY/LIP levels in 48% of patients without intra-abdominal injury, leading to unnecessary CT scans ($592/scan).
Conclusions:
- Serum amylase and lipase can support clinical suspicion but are unreliable screening tools for pediatric pancreatic trauma.
- Routine use of these tests and subsequent imaging is not cost-effective and may be unjustified.
- Clinical evaluation remains paramount in diagnosing pancreatic injuries in pediatric trauma.
Background:
Injury to the pancreas is rare in pediatric trauma. Identification of pancreatic injury relies on clinical, radiographic, and laboratory data. Serum screening for pancreatic injury frequently is used but has not proven to correlate well with pancreatic injury. This study investigated utility and cost effectiveness of serum assessment of amylase and lipase.
Methods:
A retrospective study of 1,821 pediatric trauma patients over 64 months was conducted. A total of 293 (16%) of these patients suffered trauma to the torso 195 (11%) of whom had confirmed intraabdominal injury. Eight pancreatic injuries (4% of abdominal injuries) were identified; 5 underwent surgery for pancreatic ductal injury. One patient not operated on had a pseudocyst that required late drainage.
Results:
Serum amylase or lipase levels (AMY/LIP) were measured in 507 (28%) patients. A total of 116 (23%) had elevated AMY/LIP levels. Six of 8 with proven pancreatic injury underwent AMY/LIP testing; 5 had elevated values. Forty-eight percent of patients with elevated AMY/LIP levels had no evidence of intraabdominal injury. Seventy-four of 116 (64%) with elevated AMY/LIP levels underwent abdominal and pelvic computed tomography (CT) scanning, yet 38 (51%) of these had completely normal scans. Many patients with elevated AMY/LIP levels (cost, $6 per test) underwent screening CT scans (cost, $592 per test) based on AMY/LIP alone. No patient with elevated AMY/LIP levels but without clinical suspicion was proven to have pancreatic injury. Cost data are presented.
Conclusions:
Serum amylase and lipase determinations may support clinical suspicion in the diagnosis of pediatric pancreatic trauma but are not reliable or cost effective as screening tools. Costs incurred from routine serum amylase and lipase or from imaging tests subsequent to elevated serum values may be significant and unjustified.
Related Concept Videos
Acute Pancreatitis II: Clinical Manifestations and Management
Chronic Pancreatitis II: Collaborative Care
Assessment:
Serum Laboratory Studies, Stool Test, Breath Test
Acute Pancreatitis II: Pathophysiology

